Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified sodium hyaluronate gel with lidocaine for nasolabial fold correction: split-face pain study
ChiCTR2400081881Phase 3Not yet recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Mar 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of sodium hyaluronate in nasolabial fold (2 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Injection pain. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
sodium hyaluronate
03
Conditions
nasolabial fold
Beyond the preview
Go deeper on ChiCTR2400081881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081881.